KOSELUGO 25 MG
SELUMETINIB (SELUMETINIB SULFATE) : 25 MG · DIN 02530147 · ALEXION PHARMA GMBH
Health Canada status: MARKETED
What is KOSELUGO?
KOSELUGO 25 MG contains SELUMETINIB (SELUMETINIB SULFATE) : 25 MG. It is listed in the Health Canada Drug Product Database under DIN 02530147, held by ALEXION PHARMA GMBH, supplied as CAPSULE for ORAL administration. Health Canada currently lists it as marketed, status dated 02-Oct-2024. Nexara Health is a licensed Canadian wholesale distributor (DEL 3-002896-A) and can source this product for hospitals, pharmacies and clinics. Availability and lead time are confirmed per order.
Product details and regulatory record
| DIN | 02530147 |
|---|---|
| Brand name | KOSELUGO |
| Generic / active ingredient | SELUMETINIB (SELUMETINIB SULFATE) : 25 MG |
| Manufacturer | ALEXION PHARMA GMBH |
| Strength | 25 MG |
| Dosage form | CAPSULE |
| Route of administration | ORAL |
| Schedule | Prescription |
| ATC code | L01EE04 SELUMETINIB |
| AHFS class | 10:00.00 |
| Biosimilar | No |
| Health Canada status | MARKETED |
| Status date | 02-Oct-2024 |
| Original market date | 2023-01-03 00:00:00 |
What can be used instead?
Other Canadian products sharing ATC code L01EE04 SELUMETINIB. 2 of 2 DINs in this group are currently marketed — marketed products are listed first, because that is what can actually be bought. These tables describe supply, not clinical equivalence: substitution rests with the prescriber or pharmacist, and interchangeability is determined provincially.
| Product | Strength | Form | Manufacturer | Health Canada status | DIN |
|---|---|---|---|---|---|
| KOSELUGO | 10 MG | CAPSULE | ALEXION PHARMA GMBH | MARKETED | DIN 02530139 |
Who else supplies SELUMETINIB worldwide?
Nexara tracks national medicine registries and published price lists across multiple markets. SELUMETINIB appears in 24 registered pack listings across 9 markets, published on 8 different national price bases. Where a Canadian route is closed, that is where an alternative route of supply starts — subject to the import rules in both countries.
Registered listings are not stock. Ask us to confirm what can actually be sourced for your order.
How can I get it?
Nexara Health supplies this product to licensed Canadian buyers — pharmacies, hospitals, clinics, licensed distributors, and clinical trial sponsors or their CROs. We confirm stock, pack size, expiry and pricing at the time of quotation. If the product is on backorder or in shortage, we identify equivalent alternatives and import options where permitted.
Ordering questions
Who can buy this from Nexara?
Licensed entities only. Nexara holds Health Canada establishment licence DEL 3-002896-A and ships only to a licensed address.
Is there a minimum order?
Yes, set per product line and per pack multiple rather than on the order total, so you are never asked to buy a part-pack. The minimum for this line is confirmed with your quote.
What is the lead time?
Confirmed per order at quotation, and it depends on current stock position and whether the product is in shortage.
Can Nexara supply this for a clinical trial?
Yes — comparator and background-therapy supply, including sourcing from other markets where a Canadian pack will not satisfy the protocol. Clinical trial supply.